Replies to post #54609 on Biotech Values

[stockdak]

MNTA: A little knowledge is a dangerous thing...

Yes I had M118 and M-Enoxaparin confused.

Still if M-Enoxaparin is a more homogenous version of Lovenox and Lovenox has about 1% of patients with HIT response (compared to 5% for UFH) the hope is that M-Enoxaparin will be more like Arixtra which shows no HIT compared to Lovenox.

DAK